Vivani Medical prices $4.5M common stock offering; Chairman participates in private placement

Vivani Medical, Inc.

Gross proceeds of $4.5M from registered direct offering (1.69M shares) and private placement (1.35M shares) at $1.48/share.
Chairman Gregg Williams purchased 1,351,351 shares in private placement at same price.
Net proceeds to fund clinical development and working capital; offering expected to close Jan. 27, 2026.
ThinkEquity acted as sole placement agent for the registered direct offering.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Vivani Medical, Inc. issued 1,351,351 shares of common stock of common stock to entity affiliated with Gregg Williams, Chairman of the Company’s board of directors for purchase price of $1.48 per share, gross proceeds of approximately $2.0 million.

Security: common stock
Shares: 1,351,351 shares of common stock
Purchaser: entity affiliated with Gregg Williams, Chairman of the Company’s board of directors
Consideration: purchase price of $1.48 per share, gross proceeds of approximately $2.0 million

Exact text from the filing

Vivani Medical, Inc. (the “Company”) entered into a Share Purchase Agreement, dated January 25 , 2026 (the “Purchase Agreement”), with an entity affiliated with Gregg Williams, Chairman of the Company’s board of directors (the “Purchaser”) for the purchase of an aggregate of 1,351,351 shares of common stock, par value of $0.0001 per share (“Common Stock”) of the Company at a purchase price of $1. 4 8 per share (the “Private Placement Shares”), the last reported sale price of the Common Stock on January 2 3 , 2026 . This private placement of Common Stock resulted in gross proceeds of approximately $ 2.0 million to the Company.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Vivani Medical, Inc. entered into Share Purchase Agreement with an entity affiliated with Gregg Williams, Chairman of the Company’s board of directors (the “Purchaser”) valued at gross proceeds of approximately $2.0 million (effective 2026-01-25).

Action: entry
Agreement: equity purchase
Counterparty: an entity affiliated with Gregg Williams, Chairman of the Company’s board of directors (the “Purchaser”)
Value: gross proceeds of approximately $2.0 million
Effective: 2026-01-25

Exact text from the filing

Vivani Medical, Inc. (the “Company”) entered into a Share Purchase Agreement, dated January 25 , 2026 (the “Purchase Agreement”), with an entity affiliated with Gregg Williams, Chairman of the Company’s board of directors (the “Purchaser”) for the purchase of an aggregate of 1,351,351 shares of common stock

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Vivani Medical, Inc. entered into Placement Agency Agreement with ThinkEquity LLC (the “Agent”) valued at gross proceeds of approximately $2.5 million (effective 2026-01-25).

Action: entry
Agreement: underwriting
Counterparty: ThinkEquity LLC (the “Agent”)
Value: gross proceeds of approximately $2.5 million
Effective: 2026-01-25

Exact text from the filing

the Company also entered into a Placement Agency Agreement, dated January 25 , 2026 (the “Placement Agency Agreement”) with ThinkEquity LLC (the “Agent”) relating to the sale by the Company of 1,689,200 shares of the Company’s Common Stock

View on SEC.gov

32 equity issuances filed in the last 30 days. Browse all equity issuances →

Vivani Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001753926-26-000194

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.